Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace, a segment of General Electric Company (NYSE: GE), is a global leader in the design, manufacture, and service of aircraft engines. Founded in 1892 and headquartered in Boston, GE has a rich history tied to American inventor Thomas Edison. While GE operates in multiple industries including power, renewable energy, digital industry, and additive manufacturing, GE Aerospace remains its core business.
With nearly 70,000 commercial and military engines installed worldwide, GE Aerospace generates significant revenue from the recurring service and maintenance of these engines. The company's partnership with Safran in their CFM joint venture further solidifies its leadership in aerospace propulsion.
Recent achievements for GE Aerospace include significant deals and technological advancements. Notably, GE Aerospace retained its portfolio of intellectual property related to aerospace and defense technologies after a definitive agreement with Dolby Laboratories to acquire GE Licensing. This acquisition, valued at $429 million and expected to close by the end of fiscal year 2024, highlights GE Aerospace's focus on its core aerospace and defense markets.
In another major development, GE Vernova's Onshore Wind business, a part of GE's power and renewable energy segment, announced a landmark deal with Pattern Energy. This deal involves the supply of 674 wind turbines for the SunZia Wind project, set to be the largest wind project in the Western Hemisphere. This project is a testament to GE's commitment to renewable energy and showcases its ability to deliver large-scale, high-efficiency projects.
Moreover, GE Aerospace continues to innovate with products like the 3.6-154 wind turbine, which incorporates advanced AI-trained blade manufacturing processes. This turbine is built to meet U.S. market needs and is part of GE's strategy to drive quality and reliability across its fleet.
Financially, GE Aerospace is robust, leveraging its longstanding expertise and extensive global network to maintain a strong market position. The company's continuous investments in technology, such as the new manufacturing assembly line for its Onshore Wind business in Schenectady, New York, reflect its commitment to enhancing American manufacturing and supporting climate change goals.
GE Aerospace's mission to define the future of flight and bring innovative solutions to the aerospace and defense sectors is backed by its substantial workforce of 52,000 employees globally. The company's operations aim to provide affordable, reliable, sustainable, and secure energy solutions, reinforcing its leadership in the industry.
GE Current has appointed DeFazio Industries as its newest agent to enhance its lamp and ballast offerings in Virginia. DeFazio, a rapidly growing representation firm established in 2016, will also focus on promoting Current's LED technology. Chip Taylor, Current’s Chief Commercial Officer, expressed confidence in DeFazio’s ability to expand their product reach, while Rick DeFazio highlighted the importance of the partnership. This collaboration aims to leverage DeFazio's extensive experience in the electrical supply industry to benefit both companies.
GE, Fraunhofer IGCV, and voxeljet AG have announced a partnership to develop the world's largest 3D printer for offshore wind applications, specifically for the GE Haliade-X turbine. This initiative aims to streamline the production of large turbine components, reducing mold production time from ten weeks to just two. Additionally, the project is expected to lower transportation costs and minimize the carbon footprint. The initial trials of this new technology are set to commence in Q1 2022, with early project launches anticipated in Q3 2021.
The Board of Directors of GE (NYSE: GE) has declared a $0.08 per share dividend on its outstanding common stock. This dividend will be payable on October 25, 2021 to shareholders of record at the close of business on September 27, 2021. The ex-dividend date is set for September 24, 2021.
GE has begun testing its second XA100 adaptive cycle engine as part of the U.S. Air Force’s Adaptive Engine Transition Program (AETP), starting August 26, 2021, at its facility in Evendale, Ohio. This prototype aims to advance technology maturation and risk reduction. GE's first XA100 engine tests began in December 2020. Innovations include a high-thrust mode and improved fuel efficiency, potentially reducing emissions by 25%. Over $4 billion has been invested in adaptive cycle engine development.
GE Healthcare has launched the AMX Navigate, a pioneering portable digital X-ray system. This innovative system features a power-assisted Free Motion telescoping column that reduces lift force by up to 70%, addressing the high incidence of musculoskeletal injuries among X-ray technologists. The Zero Click Exam solution enhances workflow efficiency by automating patient matching and protocol selection, potentially eliminating 100% of user interface clicks. Additionally, the system integrates AI for critical condition identification and image quality checks, streamlining the examination process for improved patient care.
GE Digital has been recognized as a leader in the Asset Performance Management (APM) software by Verdantix. The APM market, currently valued at $2.7 billion, is expected to grow to $4.4 billion by 2025. GE Digital's APM software excels in asset health monitoring, failure prediction, and maintenance optimization, achieving perfect scores in these areas. Their Industrial Managed Services have saved customers over $1.5 billion in avoided costs. This recognition underscores the company's commitment to enhancing asset reliability and operational performance across various industries.
GE Healthcare has launched Edison True PACS, a cloud-based Picture Archive and Communication System (PACS) aimed at addressing the acute shortage of radiologists and increasing demand for imaging scans. This innovative system enhances radiologist efficiency by incorporating AI-enabled tools for improved diagnostic accuracy and reduced errors. Currently available in the U.S., it offers a scalable and cost-effective solution, making advanced imaging technologies more accessible for small imaging centers and hospitals. The rollout is expected to expand to other regions in 2022.
GE Healthcare has forged a strategic collaboration with Amazon Web Services (AWS) to enhance AI and cloud-based imaging solutions. This initiative aims to transition healthcare providers from traditional models to decentralized, cloud-enabled systems, leveraging the high volume of imaging data currently underutilized. The partnership includes offering GE's Edison Health Services platform and imaging applications on AWS, enhancing clinical efficiency, and ultimately improving patient care. The initial product available will be the AI-enabled TruePACS solution, streamlining imaging processes and data management.
Malaysia Airlines has partnered with GE Digital to enhance its fuel efficiency program using GE Digital’s Fuel Insight and FlightPulse aviation software. This collaboration supports the airline's sustainability goals, which include a 15% improvement in fuel burn over the past eight years. The software aims to improve operational efficiency and reduce emissions by providing actionable intelligence to pilots and analysts. The implementation will leverage GE's Event Measurement System on Microsoft Azure, facilitating a data-driven approach to aviation.
NorthStar Medical Radioisotopes and GE Healthcare have signed an exclusive agreement for the manufacture and distribution of iodine-123 (I-123) capsules in the U.S. GE Healthcare will produce I-123 under NorthStar's label using advanced technology at its Arlington Heights facility. NorthStar will hold exclusive U.S. marketing rights for I-123 in 100µCi and 200µCi formulations. I-123 is vital for diagnosing thyroid abnormalities, including cancer, with approximately 44,280 U.S. cases expected in 2021. This partnership strengthens NorthStar's commitment to enhancing nuclear medicine.